An institutional review evaluating the outcomes and safety of eye block procedures for patients taking direct oral anticoagulants (DOACs)
Current literature (and current practice) supports the use of performing eye blocks for patients anticoagulated with warfarin[1-3]. While many providers in our practice at Massachusetts Eye and Ear (MEE) have extrapolated this data to incorporate patients taking newer Direct Oral Anticoagulants (DOACs), there is a paucity of literature discussing the safety of this practice. We therefore designed a retrospective study evaluating all patients who received an eye block while concurrently taking Apixaban, Rivaroxaban, Edoxaban, or Dabigatran. Possible complications related to DOACs include excessive bruising, retrobulbar hemorrhage, and blindness.